351 related articles for article (PubMed ID: 35675487)
1. Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.
Borgia F; Li Pomi F; Alessandrello C; Vaccaro M; Pioggia G; Gangemi S
J Dermatol; 2022 Oct; 49(10):948-956. PubMed ID: 35675487
[TBL] [Abstract][Full Text] [Related]
2. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
Ramasamy S; Subbian S
Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
[TBL] [Abstract][Full Text] [Related]
3. Janus kinase signaling as risk factor and therapeutic target for severe SARS-CoV-2 infection.
Solimani F; Meier K; Ghoreschi K
Eur J Immunol; 2021 May; 51(5):1071-1075. PubMed ID: 33675065
[TBL] [Abstract][Full Text] [Related]
4. Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab.
Agresti N; Lalezari JP; Amodeo PP; Mody K; Mosher SF; Seethamraju H; Kelly SA; Pourhassan NZ; Sudduth CD; Bovinet C; ElSharkawi AE; Patterson BK; Stephen R; Sacha JB; Wu HL; Gross SA; Dhody K
J Transl Autoimmun; 2021; 4():100083. PubMed ID: 33521616
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs based regulation of cytokine regulating immune expressed genes and their transcription factors in COVID-19.
Khokhar M; Tomo S; Purohit P
Meta Gene; 2022 Feb; 31():100990. PubMed ID: 34722158
[TBL] [Abstract][Full Text] [Related]
6. Pityriasis Rosea after COVID-19 Infection.
Prtajin M; Ljubojević Hadžavdić S
Acta Dermatovenerol Croat; 2022 Dec; 30(4):265-266. PubMed ID: 36919396
[TBL] [Abstract][Full Text] [Related]
7. The Role of Cytokines, Chemokines, and Growth Factors in the Pathogenesis of Pityriasis Rosea.
Drago F; Ciccarese G; Broccolo F; Ghio M; Contini P; Thanasi H; Parodi A
Mediators Inflamm; 2015; 2015():438963. PubMed ID: 26451078
[TBL] [Abstract][Full Text] [Related]
8. Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic.
Liang C; Hui N; Liu Y; Qiao G; Li J; Tian L; Ju X; Jia M; Liu H; Cao W; Yu P; Li H; Ren X
Phytomed Plus; 2021 May; 1(2):100027. PubMed ID: 35399819
[TBL] [Abstract][Full Text] [Related]
9. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
10. A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection.
Ahmed F
Front Immunol; 2020; 11():590459. PubMed ID: 33362771
[TBL] [Abstract][Full Text] [Related]
11. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological mechanism of immunomodulatory agents for the treatment of severe cases of COVID-19 infection.
Bahari Z; Jangravi Z; Ghoshooni H; Afarinesh MR; Meftahi GH
Inflamm Res; 2021 Apr; 70(4):389-405. PubMed ID: 33608746
[TBL] [Abstract][Full Text] [Related]
13. Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.
Sasidharakurup H; Kumar G; Nair B; Diwakar S
OMICS; 2021 Dec; 25(12):770-781. PubMed ID: 34807729
[TBL] [Abstract][Full Text] [Related]
14. The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.
Dursun R; Temiz SA
Dermatol Ther; 2020 Jul; 33(4):e13730. PubMed ID: 32475003
[TBL] [Abstract][Full Text] [Related]
15. The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection.
Qudus MS; Tian M; Sirajuddin S; Liu S; Afaq U; Wali M; Liu J; Pan P; Luo Z; Zhang Q; Yang G; Wan P; Li Y; Wu J
J Med Virol; 2023 Apr; 95(4):e28751. PubMed ID: 37185833
[TBL] [Abstract][Full Text] [Related]
16. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
[TBL] [Abstract][Full Text] [Related]
17. Pityriasis rosea Gibert triggered by SARS-CoV-2 infection: A case report.
Birlutiu V; Birlutiu RM; Iancu GM
Medicine (Baltimore); 2021 Apr; 100(14):e25352. PubMed ID: 33832113
[TBL] [Abstract][Full Text] [Related]
18. Adaptive immunity to SARS-CoV-2 infection: A systematic review.
Silva MJA; Ribeiro LR; Lima KVB; Lima LNGC
Front Immunol; 2022; 13():1001198. PubMed ID: 36300105
[TBL] [Abstract][Full Text] [Related]
19. The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
Hsu RJ; Yu WC; Peng GR; Ye CH; Hu S; Chong PCT; Yap KY; Lee JYC; Lin WC; Yu SH
Front Immunol; 2022; 13():832394. PubMed ID: 35464491
[TBL] [Abstract][Full Text] [Related]
20. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.
Drago F; Broccolo F; Ciccarese G
Clin Dermatol; 2022; 40(5):586-590. PubMed ID: 35093476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
